First real-world studies report glecaprevir/pibrentasvir to be effective and well tolerated in chronic HCV infection
12 April 2018, Paris, France: The results of the first real-world studies assessing the effectiveness and safety of glecaprevir/pibrentasvir (G/P) ...








